Editas Medicine (EDIT) Accumulated Depreciation & Amortization (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Accumulated Depreciation & Amortization data on file, last reported at $28.4 million in Q4 2025.

• Quarterly Accumulated Depreciation & Amortization fell 10.41% year-over-year to $28.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $28.4 million (down 10.41% YoY) and the FY2025 annual result came in at $28.4 million, down 10.41% from the prior year.
• Accumulated Depreciation & Amortization grew to $28.4 million in Q4 2025 per EDIT's latest filing, from $27.5 million in the prior quarter.
• Across five years, Accumulated Depreciation & Amortization topped out at $31.6 million in Q4 2024 and bottomed at $12.0 million in Q1 2021.
• The 5-year median for Accumulated Depreciation & Amortization is $24.2 million (2023), against an average of $22.9 million.
• The widest annual swing landed in 2021, when Accumulated Depreciation & Amortization jumped 49.79%; it then declined 10.41% in 2025.
• Tracing EDIT's Accumulated Depreciation & Amortization over 5 years: stood at $15.5 million in 2021, then jumped by 38.81% to $21.5 million in 2022, then increased by 21.99% to $26.3 million in 2023, then grew by 20.52% to $31.6 million in 2024, then retreated by 10.41% to $28.4 million in 2025.
• Per Business Quant, the three latest EDIT Accumulated Depreciation & Amortization figures stand at $28.4 million (Q4 2025), $27.5 million (Q3 2025), and $26.8 million (Q2 2025).

Peer Comparison